Randomized controlled study of Jianpi Huashi Zhixue Prescription on secondary prevention of esophagogastric variceal bleeding in patients with hepatitis B cirrhosis

Yi-xin HOU; Qun ZHANG; Hao YU; Yu-ying YANG; Yu-yong JIANG

doi:10.16025/j.1674-1307.2022.02.001

您当前的位置：

首页 >

文章列表页 >

Randomized controlled study of Jianpi Huashi Zhixue Prescription on secondary prevention of esophagogastric variceal bleeding in patients with hepatitis B cirrhosis

更新时间：2023-02-15

- Randomized controlled study of Jianpi Huashi Zhixue Prescription on secondary prevention of esophagogastric variceal bleeding in patients with hepatitis B cirrhosis
- Beijing Journal of Traditional Chinese Medicine Vol. 41, Issue 2, Pages: 107-112(2022)
- 作者机构：
  
  1.首都医科大学附属北京地坛医院中西医结合二科，北京 100015
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2022.02.001
  CLC：
扫描看全文
侯艺鑫，张群，于浩，等.健脾化湿止血方对乙肝肝硬化食管胃静脉曲张破裂出血患者二级预防的随机对照研究［J］.北京中医药，2022，41（2）：107-112.

HOU Yi-xin,ZHANG Qun,YU Hao,et al.Randomized controlled study of Jianpi Huashi Zhixue Prescription on secondary prevention of esophagogastric variceal bleeding in patients with hepatitis B cirrhosis[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(02):107-112.
侯艺鑫，张群，于浩，等.健脾化湿止血方对乙肝肝硬化食管胃静脉曲张破裂出血患者二级预防的随机对照研究［J］.北京中医药，2022，41（2）：107-112. DOI： 10.16025/j.1674-1307.2022.02.001.

HOU Yi-xin,ZHANG Qun,YU Hao,et al.Randomized controlled study of Jianpi Huashi Zhixue Prescription on secondary prevention of esophagogastric variceal bleeding in patients with hepatitis B cirrhosis[J]. Beijing Journal of Traditional Chinese Medicine,2022,41(02):107-112. DOI： 10.16025/j.1674-1307.2022.02.001.

摘要

目的,2,探讨健脾化湿止血方对乙肝肝硬化合并食管胃静脉曲张破裂出血（EGVB）患者1年内发生再出血的临床疗效。,方法,2,选取2018年5月—2020年5月首都医科大学附属北京地坛医院收治的肝硬化EGVB患者110例，随机分为中西医结合组、西医对照组，各55例。西医对照组给予内科综合治疗，中西医结合组在此基础上加用健脾化湿止血方，疗程12周，随访至48周。观察2组患者48周内再出血率以及肝功能、中医证候评分的变化。,结果,2,第48周时，中西医结合组出血率45.5 %，西医对照组为63.6 %，2组差异有统计学意义（,P,<,0.05）。2组肝功能均较治疗前有改善，ALT、AST、TBIL均较治疗前下降，但差异无统计学意义（,P,>,0.05）；中西医结合组治疗后ALB水平与西医对照组相比显著升高，差异有统计学意义（,P,<,0.05）。中西医结合组自治疗8周起，中医证候评分较西医对照组显著下降，差异有统计学意义（,P,<,0.05）。,结论,2,健脾化湿止血方能促进乙肝肝硬化患者蛋白合成，改善中医症状，降低EGVB患者1年内再出血风险。

Abstract

Objective,2,To explore the clinical effect of Jianpi Huashi Zhixue Prescription for patients with hepatitis B cirrhosis accompanied with esophagogastric variceal bleeding (EGVB) within one year.,Methods,2,A total of 110 patients with EGVB cirrhosis admitted to Beijing Ditan Hospital Affiliated to the Capital Medical University from May 2018 to May 2020 were selected and randomly divided into integrated traditional Chinese and western medicine treatment group and western medicine control group of 55 in each one, the course of treatment was 12 weeks with 48 weeks of following up.The re-bleeding rate,liver function and the changes of TCM syndrome score of two groups were observed.,Results,2,After 48 weeks of follow-up,the bleeding rate was 45.5% in the group of integrated traditional Chinese and western medicine and 63.6% in the control group.There was statistical difference between the two groups (,P,<,0.05).After treatment,the liver function in 2 groups was both improved,ALT,AST and TBIL were decreased,but there was no statistical difference(,P,>,0.05).The ALB level of patients in the integrated traditional Chinese and western medicine treatment group after treatment was significantly higher than that in the control group,with statistical difference(,P,<,0.05).After 8 weeks of treatment,the TCM syndrome score in the integrated Chinese and western medicine group was significantly lower than that in the western medicine control group,the difference was statistically significant(,P,<,0.05).,Conclusion,2,Jianpi Huashi Zhixue Prescription can improve the liver function,promote protein synthesis and TCM symptoms in patients with hepatitis B cirrhosis,thereby reducing the risk of re-bleeding in those patients with EGVB within 1 year.

关键词

健脾化湿止血方乙肝肝硬化食管胃静脉曲张出血中医治法

Keywords

Jianpi Huashi Zhixue Prescriptionhepatitis Bliver cirrhosisesophageal and gastric varices bleedingtherapeutic method of TCM

references

HOLSTER IL,TJWA ET,MOELKER A,et al.Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding[J].Hepatology，2016,63(2):581-589.

CARBONELL N,PAUWELS A,SERFAT L,et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades[J].Hepatology，2004，40:652-659.

中华医学会肝病学分会，中华医学会消化病学分会，中华医学会消化内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血防治指南[J].中华内科杂志，2016,55(1)：57-72.

DE FRANCHIS R.Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol,2010,53(4):762-768.

肖定洪，顾杰，蔡虹，等.扶正化瘀胶囊预防肝硬化患者食管静脉曲张破裂出血的随机对照多中心临床研究[J].中华肝脏病杂志，2014,22(8):594-599.

顾杰，周扬，洪嘉禾，等.扶正化瘀方对DMN肝硬化模型大鼠门静脉压力的影响[J].世界华人消化杂志，2008,16(10):1042-1046.

GU J,ZHANG Q,XUE D,et al.A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis[J].Evid Based Complement Alternat Med,2013, 2013: 534960.

LIU C,JIANG CM,LIU CH,et al.Effect of Fuzhenghuayu decoction on vascular endothelial growth factor secretion in hepatic stellate cells[J].Hepatobiliary Pancreat Dis Int,2002,1(2):207-210.

周仲瑛.中医内科学[M].北京：中国中国医药出版社，2006：386.

陈灏珠．实用内科学［M］．2版.北京：人民卫生出版社，2001:1850.

CELIAC D，JULI CB，CAROLINA C.World Gastroenterology Organisation Global Guideline:Esophagealvarices[OL].（2014-01-14）[2021-05-10].http://www.worldgastroenterology.org/guidelines/global-guidelines/esophageal-varices/esophageal-varices-englishhttp://www.worldgastroenterology.org/guidelines/global-guidelines/esophageal-varices/esophageal-varices-english.

郑筱萸．中药新药临床研究指导原则（试行）［M］．北京：中国医药科技出版社，2002:361-390.

GARCIA TSAO G，SANYAL AJ，GRACE ND，et al．Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis[J].Hepatology,2007，46(3)：922-938.

朱龙川，文卓夫，徐龙，等.肝硬化胃食管静脉曲张1年内再出血及其预测指标分析[J].广东医学，2012(16)：2441-2444.

古川，李璐，王军，等.内镜下套扎术治疗肝硬化食管静脉曲张的疗效及术后再出血的危险因素分析[J].临床肝胆杂志,2014(12)：1279-1282.

刘洋.肝硬化伴肠功能障碍中西医结合治疗的临床研究及中医证候分析[D].北京：北京中医药大学,2014.

杨天翼.健脾化湿解毒方对TAA诱导的急性肝衰竭小鼠模型的影响[D].北京：北京中医药大学,2013.

肖蛲，涂晋文，李天望．涂晋文教授治疗门脉高压性胃病肝郁脾虚证经验[J]．湖北中医药大学学报，2015（6）：96-98.

蒋南飞，葛来安．益气清热活血方治疗门脉高压性胃病40例［Ｊ］．实用中西医结合临床，2013（6）：19-20.

欧阳翔，张国霞.张锡纯治吐血浅析[J]．北京中医药，2016,35(8)：757-759．

BOSE S, HAN KW, LEE MJ,et al.Intestinal protective effects of herbal-basedformulations in rats against neomycin insult[J].Evid Based Complement Alternat Med,2013,2013:161-178.

LI M,WANG P,SUN C,et al.Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway[J].PloS one,2013,8(5)：e61944.

黄自平,梁扩寰.黄芩、黄连对正常及肝硬化犬门脉血液动力学的影响[J].中华消化杂志,2014,14（1）：31-33.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Discussion on syndrome differentiation and treatment of thrombocytopenia in liver cirrhosis based on Ying-Wei Theory

Related Author

No data

Related Institution

Department of Infectious Diseases，Guang'anmen Hospital， China Academy of Chinese Medical Sciences

International Medical Department，Guang'anmen Hospital，China Academy of Chinese Medical Sciences

⁰